IMDA (Irish Medical Devices Association) maps Irish medtech market:
This article was originally published in Clinica
The Irish Medical Devices Association (IMDA) is preparing a report on the national medical technology industry, based on an economic impact survey conducted recently across the entire industry. The association plans to present its preliminary results to Ireland's vice-prime minister, at this year's annual "influential meeting" with government to discuss enterprise-related issues, being held on March 13. The full report is due to be published by the end of next month. IMDA, which represents two-thirds of medical technology companies based in Ireland - "but a very high proportion in market terms", according to director Sharon Higgins.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.